ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Oruka Therapeutics Inc

Oruka Therapeutics Inc (HQ1)

74.50
-0.50
(-0.67%)
終了 7月6日 5:00AM

Oruka Therapeutics Inc (HQ1) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
74.50
( -0.67% )
買値
74.00
売値
75.00
出来高
0.00
0.00 日の範囲 0.00
11.80 52 週間の範囲 83.00
時価総額
前日終値
75.00
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
1,782,875 €
発行済株式数
60,312,101
配当利回り
PER
-48.52
1 株当たり利益 (EPS)
-1.92
歳入
-
純利益
-116.25M

Oruka Therapeutics Inc について

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in ... Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California. 詳細を表示

セクター
-
業界
-
ウェブサイト
本社
Menlo Park, United States
設立
-
Oruka Therapeutics Inc is listed in the sector of the Tradegate (DE) with ticker HQ1. The last closing price for Oruka Therapeutics was 75.00 €. Over the last year, Oruka Therapeutics shares have traded in a share price range of 11.80 € to 83.00 €.

Oruka Therapeutics currently has 60,312,101 shares in issue. The market capitalisation of Oruka Therapeutics is 4.49 € billion. Oruka Therapeutics has a price to earnings ratio (PE ratio) of -48.52.

HQ1 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-6-7.4534161490780.583736780.56179775DE
420.537.962962963548353.59269.48883627DE
122036.697247706454.58347.227256.13848303DE
2652.1232.58928571422.48322.423550.94721577DE
5262.7531.35593220311.88311.826636.3415374DE
15652.2234.08071748922.3835.4523630.62036345DE
26052.2234.08071748922.3835.4523630.62036345DE

HQ1 - Frequently Asked Questions (FAQ)

What is the current Oruka Therapeutics Inc share price?
The current share price of Oruka Therapeutics Inc is 74.50 €
How many Oruka Therapeutics Inc shares are in issue?
Oruka Therapeutics Inc has 60,312,101 shares in issue
What is the market cap of Oruka Therapeutics Inc?
The market capitalisation of Oruka Therapeutics Inc is EUR 4.49B
What is the 1 year trading range for Oruka Therapeutics Inc share price?
Oruka Therapeutics Inc has traded in the range of 11.80 € to 83.00 € during the past year
What is the PE ratio of Oruka Therapeutics Inc?
The price to earnings ratio of Oruka Therapeutics Inc is -48.52
What is the registered address of Oruka Therapeutics Inc?
The registered address for Oruka Therapeutics Inc is 855 Oak Grove Avenue, Menlo Park, California, 94025
What is the Oruka Therapeutics Inc website address?
The website address for Oruka Therapeutics Inc is orukatx.com

HQ1 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock